InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Currie Mark G, Director. Director active across 1 companies, notably Ironwood Pharmaceuticals INC. Cumulatively, 6 reports have been recorded. Total volume traded: €451k. The latest transaction was filed on 7 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€2m190,383 shares@ €10.88930.35% mcap82.1% of flow
Class A Common Stock
SEC:0001209191-22-035443:0·
021,571 shares0
Class A Common Stock
SEC:0001209191-22-033983:0·
€225,36123,571 shares@ €9.56090.038% mcap100.0% of flow
Class A Common Stock
SEC:0001209191-21-040892·
€225,36123,571 shares@ €9.56090.038% mcap8.9% of flow
Class A Common Stock
SEC:0001209191-21-040892:0·
022,766 shares0
Class A Common Stock
SEC:0001209191-21-038179·
022,766 shares0
Class A Common Stock
SEC:0001209191-21-038179:0·
6 of 6 declarations
About Currie Mark G
Mark G. Currie serves as a board member at IRONWOOD PHARMACEUTICALS INC. He contributes to the strategic direction of the company, ensuring that decisions made within the board align with growth objectives. His expertise in the pharmaceutical sector is a valuable asset.
